Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Histopathology|May 1, 1994
A comparative analysis of grading systems in renal adenocarcinomaD Lanigan, R Conroy, C Barry-Walsh, et al.
Cancer Research|March 1, 1995
Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neckR Michalides, N van Veelen, A Hart, et al.
Histopathology|January 16, 2007
Heterogeneous expression of alpha-methylacyl-CoA racemase in prostatic cancer correlates with Gleason scoreA J Murphy, C A Hughes, G Lannigan, et al.
Virchows Archiv : an International Journal of Pathology|January 1, 1994
KP-1: not a specific marker. Staining of 137 sarcomas, 48 lymphomas, 28 carcinomas, 7 malignant melanomas and 8 cystosarcoma phyllodesM Cassidy, B Loftus, A Whelan, et al.
The Journal of Hand Surgery|January 31, 2006
Use of a headless compressive screw for distal interphalangeal joint arthrodesis in digits: clinical outcome and review of complicationsJean-Paul Brutus, Andrew K Palmer, John F Mosher, et al.
Journal of Clinical Pathology|March 25, 2006
Topoisomerase II-alpha expression increases with increasing Gleason score and with hormone insensitivity in prostate carcinomaC Hughes, A Murphy, C Martin, et al.
European Journal of Cancer (Oxford, England : 1990)|September 8, 2006
Rapid assessment breast clinics--evolution through auditD P Toomey, R A Cahill, N Birido, et al.
British Journal of Cancer|April 25, 2007
In silico mining identifies IGFBP3 as a novel target of methylation in prostate cancerA S Perry, B Loftus, R Moroose, et al.
Clinical Immunology (Orlando, Fla.)|February 24, 2009
Autologous attenuated T-cell vaccine (Tovaxin) dose escalation in multiple sclerosis relapsing-remitting and secondary progressive patients nonresponsive to approved immunomodulatory therapiesB Loftus, B Newsom, M Montgomery, et al.
Cancer|January 15, 1997
Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpressionJ A Akervall, R J Michalides, H Mineta, et al.
Pageof 3